Projects per year
Fingerprint Dive into the research topics where Mark Slifka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Virus Diseases
Medicine & Life Sciences
T-Lymphocytes
Medicine & Life Sciences
Viruses
Medicine & Life Sciences
Vaccination
Medicine & Life Sciences
Vaccines
Medicine & Life Sciences
Immunity
Medicine & Life Sciences
Lymphocytic choriomeningitis virus
Medicine & Life Sciences
Smallpox
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1976 2017
Dengue Vaccines
Dengue Virus
Inactivated Vaccines
Vaccines
Attenuated Vaccines
Pacific NorthWest Regional Center of Excellence (PNWRCE)
Streblow, D., Slifka, M., McWeeney, S., Axthelm, M., Moses, A., Nelson, J., Baric, R., Landfear, S., Nikolich-Zugich, J., Barklis, E., Gale, M., Katze, M., Kawaoka, Y., Bevan, M., Smith, R., Maizels, N., Frueh, K., Labeaud, A. D., Ryman, K., Chanda, S., Galloway, D. A. & Fruh, K.
4/20/09 → 2/28/15
Project: Research project
Northwestern United States
National Institute of Allergy and Infectious Diseases (U.S.)
Vulnerable Populations
Research
Vaccines
Development of a Safe and Effective Vaccine Against West Nile Virus
4/15/09 → 3/31/15
Project: Research project
West Nile Virus Vaccines
West Nile virus
Virus Diseases
Vaccines
National Institute of Allergy and Infectious Diseases (U.S.)
Research Output 1995 2019
1
Citation
(Scopus)
Advanced oxidation technology for the development of a next-generation inactivated West Nile virus vaccine
Quintel, B. K., Thomas, A., Poer DeRaad, D. E., Slifka, M. & Amanna, I. J., Jan 1 2019, (Accepted/In press) In : Vaccine.Research output: Contribution to journal › Article
West Nile Virus Vaccines
West Nile virus
Inactivated Vaccines
Virus Inactivation
Vaccines
1
Citation
(Scopus)
An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults
Woods, C. W., Sanchez, A. M., Swamy, G. K., McClain, M. T., Harrington, L., Freeman, D., Poore, E. A., Slifka, D. K., Poer DeRaad, D. E., Amanna, I. J., Slifka, M., Cai, S., Shahamatdar, V., Wierzbicki, M. R., Amegashie, C. & Walter, E. B., Jan 1 2019, (Accepted/In press) In : Vaccine.Research output: Contribution to journal › Article
West Nile Virus Vaccines
West Nile virus
Inactivated Vaccines
placebos
Placebos
Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses
Slifka, M. & Amanna, I. J., Jan 1 2019, In : Frontiers in immunology. 10, 1 p.Research output: Contribution to journal › Review article
Open Access
Antibody Formation
Immunity
Vaccines
Plasma Cells
Vaccination
Dengue Serostatus and Dengue Vaccine Safety and Efficacy
Slifka, M. & Amanna, I. J., Nov 15 2018, In : The New England journal of medicine. 379, 20, 1 p.Research output: Contribution to journal › Letter
Dengue Vaccines
Dengue
Safety
6
Citations
(Scopus)
Heterogeneity and longevity of antibody memory to viruses and vaccines
Antia, A., Ahmed, H., Handel, A., Carlson, N. E., Amanna, I. J., Antia, R. & Slifka, M., Aug 10 2018, In : PLoS Biology. 16, 8, e2006601.Research output: Contribution to journal › Article
Viruses
Immunity
Vaccines
immunity
vaccines